163 related articles for article (PubMed ID: 2209714)
1. Clozapine fails to prevent the development of haloperidol-induced behavioral hypersensitivity in a cotreatment paradigm.
Carvey PM; Nath ST; Kao LC; Zhang TJ; Lin DH; Singh R; Amdur RL; Klawans HL
Eur J Pharmacol; 1990 Aug; 184(1):43-53. PubMed ID: 2209714
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic alterations in cotreatments attenuating haloperidol-induced hypersensitivity.
Carvey PM; Kao LC; Zhang TJ; Amdur RL; Lin DH; Singh R; Klawans HL
Pharmacol Biochem Behav; 1990 Feb; 35(2):291-300. PubMed ID: 2320636
[TBL] [Abstract][Full Text] [Related]
3. Differential alteration of striatal D-1 and D-2 receptors induced by the long-term administration of haloperidol, sulpiride or clozapine to rats.
Jenner P; Rupniak NM; Marsden CD
Psychopharmacology Suppl; 1985; 2():174-81. PubMed ID: 3159009
[TBL] [Abstract][Full Text] [Related]
4. The effect of thioridazine on haloperidol induced behavioral hypersensitivity.
Klawans HL; Carvey PM; Nelson D; Tanner CM; Goetz CG
Life Sci; 1986 May; 38(19):1707-14. PubMed ID: 3702600
[TBL] [Abstract][Full Text] [Related]
5. Chronic treatment with clozapine, unlike haloperidol, does not induce changes in striatal D-2 receptor function in the rat.
Rupniak NM; Hall MD; Mann S; Fleminger S; Kilpatrick G; Jenner P; Marsden CD
Biochem Pharmacol; 1985 Aug; 34(15):2755-63. PubMed ID: 4040370
[TBL] [Abstract][Full Text] [Related]
6. Behavioral and biochemical aspects of neuroleptic-induced dopaminergic supersensitivity: studies with chronic clozapine and haloperidol.
Seeger TF; Thal L; Gardner EL
Psychopharmacology (Berl); 1982; 76(2):182-7. PubMed ID: 6805029
[TBL] [Abstract][Full Text] [Related]
7. Concurrent treatment with benztropine and haloperidol attenuates development of behavioral hypersensitivity but not dopamine receptor proliferation.
Carvey PM; Hitri A; Goetz CG; Tanner CM; Klawans HL
Life Sci; 1988; 42(22):2207-15. PubMed ID: 3374255
[TBL] [Abstract][Full Text] [Related]
8. Differential alterations in striatal dopamine receptor sensitivity induced by repeated administration of clinically equivalent doses of haloperidol, sulpiride or clozapine in rats.
Rupniak NM; Kilpatrick G; Hall MD; Jenner P; Marsden CD
Psychopharmacology (Berl); 1984; 84(4):512-9. PubMed ID: 6441952
[TBL] [Abstract][Full Text] [Related]
9. Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain.
Wilmot CA; Szczepanik AM
Brain Res; 1989 May; 487(2):288-98. PubMed ID: 2525063
[TBL] [Abstract][Full Text] [Related]
10. Behavioral evidence for supersensitivity after chronic administration of haloperidol, clozapine, and thioridazine.
Smith RC; Davis JM
Life Sci; 1976 Sep; 19(5):725-31. PubMed ID: 986527
[No Abstract] [Full Text] [Related]
11. Neuroleptic-induced hypersensitivity of striatal dopamine receptors in the rat as a model of tardive dyskinesias. Effects of clozapine, haloperidol, loxapine and chlorpromazine.
Sayers AC; Bürki HR; Ruch W; Asper H
Psychopharmacologia; 1975; 41(2):97-104. PubMed ID: 1171492
[TBL] [Abstract][Full Text] [Related]
12. Amantadine reduces haloperidol-induced dopamine receptor hypersensitivity in the striatum.
Allen RM; Lane JD; Brauchi JT
Eur J Pharmacol; 1980 Jul; 65(2-3):313-5. PubMed ID: 7190503
[TBL] [Abstract][Full Text] [Related]
13. Pharmacology of fluperlapine compared with clozapine.
Eichenberger E
Arzneimittelforschung; 1984; 34(1A):110-3. PubMed ID: 6145425
[TBL] [Abstract][Full Text] [Related]
14. Regional blockade by neuroleptic drugs of in vivo 3H-spiperone binding in the rat brain. Relation to blockade of apomorphine induced hyperactivity and stereotypies.
Köhler C; Haglund L; Ogren SO; Angeby T
J Neural Transm; 1981; 52(3):163-73. PubMed ID: 7198139
[TBL] [Abstract][Full Text] [Related]
15. Effect of thioridazine, clozapine and other antipsychotics on the kinetic state of tyrosine hydroxylase and on the turnover rate of dopamine in striatum and nucleus accumbens.
Zivkovic B; Guidotti A; Revuelta A; Costa E
J Pharmacol Exp Ther; 1975 Jul; 194(1):37-46. PubMed ID: 239221
[TBL] [Abstract][Full Text] [Related]
16. The contrasting effects of neuroleptics on transmitter release from the nucleus accumbens and corpus striatum.
de Belleroche JS; Neal MJ
Neuropharmacology; 1982 Jun; 21(6):529-37. PubMed ID: 6125910
[TBL] [Abstract][Full Text] [Related]
17. Differential liabilities of haloperidol and thioridazine for inducing apomorphine hypersensitivity.
De Veaugh-Geiss J; Devanand DP; Carey RJ
Biol Psychiatry; 1982 Nov; 17(11):1289-301. PubMed ID: 6891268
[TBL] [Abstract][Full Text] [Related]
18. [Effects of anticholinergics and clozapine on the activation of the striatal dopaminergic system in the rat by haloperidol. Pharmacological findings (author's transl)].
Sayers AC; Bürki HR
Arzneimittelforschung; 1976; 26(6):1092-3. PubMed ID: 989384
[TBL] [Abstract][Full Text] [Related]
19. Are the catecholestrogens involved in estrogen-induced striatal dopamine receptor supersensitivity?
Ferretti C; Ghi P; Blengio M; Gaietta G; Barrera G; Genazzani E
Eur J Pharmacol; 1989 Jul; 166(2):149-56. PubMed ID: 2551698
[TBL] [Abstract][Full Text] [Related]
20. Effect of scopolamine on the efflux of dopamine and its metabolites after clozapine, haloperidol or thioridazine.
Meltzer HY; Chai BL; Thompson PA; Yamamoto BK
J Pharmacol Exp Ther; 1994 Mar; 268(3):1452-61. PubMed ID: 8138957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]